Loading…
AdaptHealth Corp. is projected to rise to $12.29 by 2027, a +14% move from its current price of $10.80. AHCO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $10.60 | $10.81 | $11.02 | +0.06% |
| Aug 3 | $10.52 | $10.81 | $11.11 | +0.11% |
| Aug 4 | $10.46 | $10.82 | $11.19 | +0.17% |
| Aug 5 | $10.41 | $10.82 | $11.26 | +0.22% |
| Aug 6 | $10.37 | $10.83 | $11.31 | +0.28% |
| Aug 7 | $10.33 | $10.84 | $11.37 | +0.34% |
| Aug 8 | $10.30 | $10.84 | $11.42 | +0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.30 | $10.84 | $11.42 | +0.39% |
| Week 2 | $10.12 | $10.89 | $11.71 | +0.79% |
| Week 3 | $9.99 | $10.93 | $11.95 | +1.19% |
| Week 4 | $9.89 | $10.97 | $12.16 | +1.58% |
| Week 5 | $9.81 | $11.01 | $12.36 | +1.98% |
| Week 6 | $9.74 | $11.06 | $12.55 | +2.38% |
| Week 7 | $9.68 | $11.10 | $12.73 | +2.79% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
AdaptHealth Corp. distributes home medical equipment (HME), medical supplies, and related home services across the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments.
The company offers sleep therapy equipment and services, including continuous positive airway pressure and BiLevel services for obstructive sleep apnea, along with oxygen and home mechanical ventilation equipment and supplies, and chronic therapy services. It also provides medical devices such as continuous glucose monitors and insulin pumps for diabetes, as well as HME for patients discharged from acute care and other facilities.
AdaptHealth serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. It was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.
AdaptHealth Corp. trades under the symbol AHCO in the healthcare category, focusing on home medical equipment and related services.
The stock is currently priced at $11.21 per share, with a market capitalization of $1.53B and a rank of 2222.
The price outlook depicted in the provided forecast shows a neutral near-term for 2026, with an average price of $11.21, and a bullish, multi-year trajectory leading to higher averages by 2030 ($22.37), 2040 ($53.27), and 2050 ($122.87), with corresponding increases in implied return metrics.
A major floor 16.8% below — a decisive break under it would weaken the trend.
The nearest floor, 10.6% below — buyers have tended to step in here.
The nearest ceiling, 3.9% above — a clean break opens room to run.
A major ceiling 23.9% above — clearing it would confirm fresh momentum.
Key AHCO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AHCO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.89 | Sell | $10.82 | Sell |
| MA 10 | $10.88 | Sell | $10.80 | Buy |
| MA 20 | $10.62 | Buy | $10.68 | Buy |
| MA 50 | $10.29 | Buy | $10.60 | Buy |
| MA 100 | $10.96 | Sell | $10.61 | Buy |
| MA 200 | $10.40 | Buy | $10.42 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.27 | Neutral |
| Stoch RSI (14) | 24.63 | Neutral |
| CCI (20) | 35.86 | Neutral |
| Williams %R (14) | -40.78 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 1.98 | Buy |
| Bollinger %B (20,2) | 0.62 | Neutral |
| Stochastic %K (14) | 59.22 | Neutral |
| TRIX (15) | 0.23 | Buy |
| Awesome (5,34) | 0.49 | Buy |
| Ultimate (7,14,28) | 52.42 | Neutral |
| Momentum (10) | -0.16 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 10.83 | Sell |
| ADX (14) | 14.28 | Neutral |
| ATR (14) | 0.21 | Info |
The 30-day technical picture is bullish, with RSI14 at 70 indicating strong momentum.
The stock sits near an established resistance at $11.21, with a short-term moving average alignment where SMA50 is $10.30 and SMA200 is $10.33. Support sits at $9.53, creating a price floor beneath the current level. The 30-day price range spans from $9.96 to $12.62, signaling a fairly wide but contained move within the recent window.
Annualized volatility is reported at 30%, underscoring meaningful near-term price fluctuations.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.85 | $10.80 | $14.44 | 0% | Neutral | |
| $10.05 | $12.29 | $15.71 | +14% | Neutral | |
| $12.29 | $15.32 | $20.14 | +42% | Bullish | |
| $14.73 | $18.66 | $25.08 | +73% | Bullish | |
| $15.53 | $19.95 | $27.32 | +85% | Bullish | |
| $17.14 | $22.29 | $31.02 | +106% | Bullish | |
| $17.46 | $22.98 | $32.44 | +113% | Bullish | |
| $18.17 | $24.18 | $34.59 | +124% | Bullish | |
| $20.70 | $27.83 | $40.31 | +158% | Bullish | |
| $22.23 | $30.19 | $44.23 | +180% | Bullish | |
| $30.88 | $43.82 | $67.38 | +306% | Bullish | |
| $65.15 | $99.46 | $164.26 | +821% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $8.85 | $10.80 | $13.20 | +0.00% |
| September 2026 | $9.47 | $11.11 | $13.34 | +2.91% |
| October 2026 | $9.64 | $11.37 | $13.75 | +2.27% |
| November 2026 | $9.96 | $11.79 | $14.36 | +3.76% |
| December 2026 | $9.93 | $11.79 | $14.44 | -0.00% |
Click any year to see its month-by-month AHCO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, AHCO is projected to trade between $8.85 and $14.44, averaging $10.80 — a potential gain of 0% from today's $10.80. Price action looks broadly range-bound.
AdaptHealth Corp.'s 2027 outlook centres on $12.29, within a $10.05 to $15.71 range. That is up +14% on the projected 2026 average. That marks a +14% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, AHCO could reach as high as $20.14, with a base case around $15.32 and support toward $12.29 — roughly +42% from $10.80. Momentum favours further upside here.
Expect AHCO to range from $14.73 to $25.08 through 2029. The $18.66 average target implies a +73% move from current prices. That is up +22% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The AHCO price prediction for 2030 points to an average of $19.95 (low $15.53, high $27.32) — a potential gain of +85% on today's $10.80. Momentum favours further upside here.
In 2031, AHCO is projected to trade between $17.14 and $31.02, averaging $22.29 — a potential gain of +106% from today's $10.80. That is up +12% on the projected 2030 average. Buyers look set to stay in control over this stretch.
AdaptHealth Corp.'s 2032 outlook centres on $22.98, within a $17.46 to $32.44 range. That is up +3% on the projected 2031 average. That marks a +113% change versus current levels. Momentum favours further upside here.
By 2033, AHCO could reach as high as $34.59, with a base case around $24.18 and support toward $18.17 — roughly +124% from $10.80. Buyers look set to stay in control over this stretch.
Expect AHCO to range from $20.70 to $40.31 through 2034. The $27.83 average target implies a +158% move from current prices. That is up +15% on the projected 2033 average. Momentum favours further upside here.
The AHCO price prediction for 2035 points to an average of $30.19 (low $22.23, high $44.23) — a potential gain of +180% on today's $10.80. Buyers look set to stay in control over this stretch.
In 2040, AHCO is projected to trade between $30.88 and $67.38, averaging $43.82 — a potential gain of +306% from today's $10.80. That is up +45% on the projected 2035 average. Momentum favours further upside here.
AdaptHealth Corp.'s 2050 outlook centres on $99.46, within a $65.15 to $164.26 range. That is up +127% on the projected 2040 average. That marks a +821% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in AHCO today (≈ 92.592593 AHCO) could be worth
$9,209.46
+$8,209.46 (+821%) by 2050 · US Dollar
Based on the average projected AHCO price of $99.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AHCOwould be worth at today's price.
$1,000 invested in AHCO on Jul 31, 2025 (≈ 111.482717 AHCO) would be worth
$1,204.01
+$204.01 (+20.4%) today · 1.20× · US Dollar
Based on a AHCO entry price of $8.97 vs. today's $10.8.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.76 | $1,003.72 | +0.4% |
| 1 month ago | $10.6 | $1,018.87 | +1.9% |
| 3 months ago | $13.17 | $820.05 | -18.0% |
| 6 months ago | $10.1 | $1,069.31 | +6.9% |
| 1 year ago | $8.97 | $1,204.01 | +20.4% |
| All time (5.0y) ago | $21.84 | $494.51 | -50.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AHCO forecast.
Our base-case forecast reaches $22.00 around 2031.
Implied market cap at $22.00: $2.99B
The multi-year forecast shows substantial upside potential. By 2030, the expected average price is $22.37 with a 99.5 ROI, and by 2040 the average is $53.27 with a 375.2 ROI. By 2050 the average price is forecast at $122.87 with a 996.1 ROI. The 2030, 2040, and 2050 figures reflect a continued bullish sentiment across the long horizon.
Early-year sentiment remains neutral in 2026, then shifts to bullish thereafter, with higher average prices in 2027 and beyond. The forecast presents a clear upward trajectory over time but notes that these are estimates, not guarantees, and carry inherent uncertainty given market conditions and other factors.
Tap a question to reveal the answer.
In 2030 the forecasted average price is $22.37, with a min of $17.48 and a max of $30.47, and a ROI of 99.5 with sentiment BULLISH.
The forecast shows neutral in 2026 with an average of $11.21 and bullish momentum thereafter, reaching an average of $122.87 by 2050 with a ROI of 996.1. These are estimates and not guarantees.
No.
The current price is $11.21 per share and the market cap is $1.53B.
RSI14 is 70 (bullish), with SMA50 at $10.30 and SMA200 at $10.33. Support is $9.53 and resistance is $11.21. The 30-day range is $9.96 to $12.62, and annualized volatility is 30%.
AdaptHealth Corp. Community Discussion
0Share your AdaptHealth Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.